Kewei Wang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
Papers in
-
- Nanoplatforms for cancer theranostics 23
-
- Advanced biosensing and bioanalysis techniques 7
- RNA Interference and Gene Delivery 5
- Co-authors
- Youyong Yuan (21 shared papers)Yalan Tu (7 shared papers)Qingyu Zong (11 shared papers)Yansong Dong (7 shared papers)Maolin Jiang (12 shared papers)Jun Wang (4 shared papers)Xuan Xiao (6 shared papers)Ye Liu (6 shared papers)
- Journals
- Biomaterials (6 papers)ACS Applied Materials & Interfaces (2 papers)Acta Biomaterialia (2 papers)Journal of Biological Chemistry (2 papers)ACS Biomaterials Science & Engineering (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Kewei Wang
38 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 90
- Biomaterials 319
- Biomedical Engineering 644
- Molecular Biology 559
- Surfaces, Coatings and Films 51
- Materials Chemistry 278
Countries citing papers authored by Kewei Wang
This map shows the geographic impact of Kewei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewei Wang more than expected).
Fields of papers citing papers by Kewei Wang
This network shows the impact of papers produced by Kewei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewei Wang. The network helps show where Kewei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kewei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 122 | |
| 2 | 2020 | 116 | |
| 3 | 2012 | 86 | |
| 4 | 2007 | 76 | |
| 5 | 2022 | 67 | |
| 6 | 2021 | 63 | |
| 7 | 2020 | 51 | |
| 8 | 2020 | 48 | |
| 9 | 1999 | 45 | |
| 10 | 2021 | 39 | |
| 11 | 2024 | 36 | |
| 12 | 2018 | 35 | |
| 13 | 2021 | 34 | |
| 14 | 2017 | 34 | |
| 15 | 2020 | 30 | |
| 16 | 2017 | 30 | |
| 17 | 2022 | 25 | |
| 18 | 2022 | 24 | |
| 19 | 1997 | 24 | |
| 20 | 2007 | 23 |
About Kewei Wang
Kewei Wang is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Biotechnology and Materials Chemistry, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (23 papers), Nanoparticle-Based Drug Delivery (11 papers), Advanced biosensing and bioanalysis techniques (7 papers), Cancer Research and Treatments (6 papers), RNA Interference and Gene Delivery (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Virus-based gene therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Biomaterials (319 citations), Biomedical Engineering (644 citations), Molecular Biology (559 citations), Surfaces, Coatings and Films (51 citations) and Materials Chemistry (278 citations). Kewei Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Youyong Yuan, Yalan Tu, Qingyu Zong, Yansong Dong, Maolin Jiang, Jun Wang, Xuan Xiao, Ye Liu, Papasani V. Subbaiah and Cong‐Fei Xu. Their work appears in journals such as Biomaterials, ACS Applied Materials & Interfaces, Acta Biomaterialia, Journal of Biological Chemistry and ACS Biomaterials Science & Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.